GlobalCapital, is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Asia

Bigger WuXi Biologics block nets $1.5bn

Pharma_drugs_adobe_575x375.jpg

WuXi Biologics Holdings has raised HK$11.5bn ($1.49bn) after increasing a sale of shares in subsidiary WuXi Biologics (Cayman).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login